Royalty Pharma agreed to acquire its external manager, RP Management, in a $1.1 billion deal that it believes will pay for itself in the long-term as it aims to simplify its corporate structure.
Portfolio Receipts expected to be approximately $2,800 million, at the upper end of guidance rangeExciting development-stage pipeline with ...
Royalty Pharma said on Friday it would pay about $1.1 billion to acquire RP Management, an organization that manages the healthcare firm's operations, as it seeks to simplify its corporate structure.
Spencer Pratt managed to take some of his Taylor Swift merchandise after evacuating from his and Heidi Montag’s home amid ...
President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans. Trump ...
Bilfinger (BFLBF) is well-positioned to benefit from strong secular trends. Read more to see why I rate the stock a buy.
Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.
Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...
Spencer Pratt’s sister, Stephanie Pratt, revealed that Heidi Montag and Spencer Pratt have lost their Los Angeles home in the ...
The words “precision” and “precision healthcare” came up more than a handful of times in MM+M’s survey results. According to Ian Liu, global market leader for healthcare at Alorica, precision ...
After the FDA proposed pulling some over-the-counter cold and flu medications from shelves in the US, an Australian law firm has launched a class action suit against pharmaceutical giant Johnson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback